1. Renuncia del Principal Regulador de Medicamentos por Conducta y Toxicidad.
El director del centro de medicamentos de la FDA renunció abruptamente después de que funcionarios federales comenzaran a revisar serias preocupaciones sobre su conducta personal, aunque él alegó un ambiente de trabajo tóxico y represalias.
- Top fda official quits amid inquiry into serious concerns over his conduct trump administration the head of the us food and drug administrations drug center abruptly resigned on sunday after federal officials began reviewing serious concerns about his personal conduct, according to a.
- Fdas top drug regulator resigns after federal officials probe serious concerns washington the head of the food and drug administrations drug center abruptly resigned sunday after federal officials began reviewing serious concerns about his personal conduct, according to a government spokesperson. Dr.
- Fda drug chief signals possible exit as agency turmoil deepens the top drug regulator in the us signaled on tuesday he may retire weeks after accepting the position, adding to upheaval in the highest ranks of the us food and drug administration fda. If richard pazdur retires, finding a.
- Fdas top drug regulator, dr. George tidmarsh, is on leave and considering resigning, citing a toxic environment. He claims retaliation for criticizing a new drug review process. Abcnews.go.compoliticsfdas-top fda news.
2. Choques sobre la Aceleración de Aprobaciones y Vouchers de Prioridad.
El regulador de medicamentos expresó alarma sobre las iniciativas de la administración Trump para acelerar las aprobaciones, advirtiendo que podrían ser ilegales y representar un riesgo para la salud pública, lo que generó conflictos internos.
- Top fda drug regulator raises alarms about expediting approvals a person with knowledge, integrity, experience was hired, who wants to protect public health. He wont be there long. Gee, would trump take poorly tested meds?
- Top fda drug regulator raises alarms about expediting approvals, arguing they could threaten americans safety richard pazdur, who assumed his new role this month, has warned that new trump admin. Initiatives could be illegal and pose a risk to public health.
- Fda voucher program has become vehicle for political interference in drug review decisions, staffers say washington a new program intended to fast-track drug reviews at the food and drug administration is quicklyus news usnews.
- Cder director tidmarsh said he believed the new voucher program injected politics into the drug review program, superseding decisions based on science autocracy antiscience fascists authoritarianism.
3. Rotación Extrema en el Liderazgo del Centro de Evaluación de Medicamentos (CDER).
La inestabilidad en la dirección del CDER, la división más grande de la FDA, se hizo evidente con múltiples cambios de liderazgo en un corto período, lo que genera preocupación sobre la estabilidad y la experiencia en la agencia.
- The center cannot hold richard pazdur, an oncologist longtime fda official, was named head of the fdas center for drug evaluation and research this month. The center regulates otc most rx meds. Now, pazdur has questioned several plans developed 14.
- The fdas center for drug evaluation research has had 5 directors in one year the new director, tracy høeg, is a vaccine skeptical sports medicine doc with 0 regulatory expertise i dont know that i could have thought of anyone worse for this position.
- 5th fda drug approval head in 11 months. No other president or hhs secretary in history has overseen such a level of turnover. Yahoo.comnewsarticle.
- Rick pazdur to replace george tidmarsh at fda drug center washington ap the food and drug administration on tuesday named a longtime regulator of cancer medicines to.
4. Nombramiento de Tracy Beth Høeg y Alarmas por Falta de Experiencia.
El nombramiento de Tracy Beth Høeg como directora interina del CDER generó alarma entre los funcionarios de la FDA, quienes señalaron su falta de experiencia en supervisión de revisiones de medicamentos o ensayos clínicos.
- Theyve installed an anti vaxer as acting director of the fdas center for drug evaluation and research.
- Putting tracy beth in charge is like dropping an atom bomb, one agency source said, adding that multiple top-level officials are preparing resignations. Its an extinction level event. Tracy beth høeg has never supervised a drug review, never has conducted a clinical trial. She doesnt understand laws and regulations.
- Utterly unqualified embattled fda taps vaccine opponent for top drug regulator position.
- She doesnt seem to hav any of th qualifications for running th drug-regulation dept, sd jonathan howard, a neurologist psychiatrist who hs closely tracked covid contrarians, includg in hs new book, everyone else is lying to you. Shes never run a randomizd controlld trial. She hs no expertise.
5. Conflicto en la Dirección de Vacunas y Críticas de Ex-Líderes.
El principal regulador de vacunas de la FDA afirmó en un memorando interno que al menos 10 niños murieron a causa de las vacunas contra el COVID-19, lo que llevó a propuestas de protocolos de aprobación más estrictos, criticados por ex-líderes de la agencia.
- Fda claims covid shots killed 10 children and vows new vaccine rules the director of the food and drug administrations vaccine division told agency staff in a memo that an internal review found that at least 10 children died after and because of receiving a covid-19 vaccine. The 3,000-word memo,.
- 12 ex-fda leaders criticize claims made by agencys current vaccine chief a dozen prior leaders of the u.s. Food and drug administration appointed by republicans and democrats alike issued a scathing denunciation of new fda assertions casting doubt on vaccine safety. The former officials said.
- Experts say strict new fda protocol for vaccine approval is dangerous and irresponsible us news the leading vaccine regulator at the food and drug administration fda has announced a far stricter course for federal vaccine approvals, following claims from his team that covid vaccines were.
- A slow-boiling feud between vinay prasad and his staff at the food and drug administration is threatening the future of the center that regulates the nations vaccines, biological products, and blood supply. .